Selskabets formål er at drive virksomhed med handel, fabrikation og investering samt anden virksomhed, der står i forbindelse hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1 mia. | 24.1 mio. | 913 mio. | 678.3 mio. | 724 | |
CVR: 21852902
Secondary names: Seahorse Bioscience Europe ApS, Prozyme Europe ApS
3 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 1.730 companies in Engroshandel med andre maskiner og andet udstyr
Comparison is based on industry median values
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
BDO Holding VII, statsautoriseret revisionsaktieselskab resigned as auditor
Kasper Ib Schiermer Jørgensen joined the board
Lene Klejs Stuhr left the board
Companies in the same industry and area
CVR 17150774
CVR 13919941
CVR 36708980
CVR 42415316
CVR 19993345
The financial health of AGILENT TECHNOLOGIES DENMARK ApS appears stable, with a solid equity position of 678,345,000 DKK in 2025. Revenue has shown slight fluctuations, peaking at 1,062,728,000 DKK in 2021, but has generally remained around the 1 billion DKK mark, with 1,018,130,000 DKK reported in 2025. Profitability has been inconsistent, with a notable drop from 61,380,000 DKK in 2024 to 24,092,000 DKK in 2025, indicating potential margin pressures. The company's equity growth over the years suggests a strong foundation, but the declining profit trend raises concerns about operational efficiency and market competitiveness within the machinery and equipment wholesale industry.
AI-generated summary
companydata.dk